The potential impact on CRC detection at various f-Hb cut-offs was examined using combined data from three Scottish Health Boards where 1.85% patients with f-Hb in the range 10–19 μg Hb/g faeces who underwent colonoscopy had CRC.10 This evidence concerns the gene GSTM1 and colorectal carcinoma.